Dermatitis, atopic is a medical condition with active clinical research programs worldwide.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT03720470	Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	COMPLETED	PHASE3
NCT03054428	Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis	COMPLETED	PHASE3
NCT03627767	Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects	COMPLETED	PHASE3
NCT06790121	A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis	COMPLETED	—
NCT03422822	Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis	COMPLETED	PHASE3
NCT06790121	A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis	COMPLETED	—
NCT03428646	Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)	ACTIVE_NOT_RECRUITING	—
NCT06881251	A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)	ACTIVE_NOT_RECRUITING	PHASE2
NCT02277769	Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis	COMPLETED	PHASE3
NCT03687359	Observational Evaluation of Atopic Dermatitis in Pediatric Patients	ACTIVE_NOT_RECRUITING	—

Related Pages

All Dermatitis, atopic trials All trials in Plainfield, United States